Prostate Cancer

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

White button mushrooms promoted antitumor activity among men with prostate cancer, according to results of an ongoing randomized phase 2 trial.

Cancer incidence has continued to rise in the U.S. since the 1990s — particularly among women and younger adults, according to an American Cancer Society report.

Men treated with radiotherapy and prostatectomy for prostate cancer exhibit significantly higher risk for numerous urinary and sexual complications compared with the general population, according to results of a cohort study.

Regular physical activity prior to a cancer diagnosis lowered a patient’s risk for disease progression and death, according to study findings.

More men with limited life expectancy and certain localized prostate cancers have received definitive treatment over the past 2 decades despite shifts toward active surveillance, according to results of a retrospective study.

As 2024 comes to a close, Healio is pleased to present our most widely read oncology and hematology content from the past 12 months.

The role of AI in oncology and hematology expanded dramatically in 2024.

Although patients undergoing active surveillance for low-risk cancers generally have a favorable prognosis, oncologists should take steps to manage any anxiety and helplessness patients may be experiencing, according to a viewpoint paper.

An AI model classified risk for prostate cancer metastasis more accurately than standard guidelines, suggesting the approach could be used to reduce overtreatment or undertreatment.